The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Safonova T.N.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Gladkova O.V.

Research Institute of Eye Diseases, 11 A, B, Rossolimo St., Moscow, Russian Federation, 119021

Boev V.I.

Research Institute of Eye Diseases, 11 A, B, Rossolimo St., Moscow, Russian Federation, 119021

Oxidative stress correction in the treatment of severe keratoconjunctivitis sicca in patients with Sjorgen’s syndrome

Authors:

Safonova T.N., Gladkova O.V., Boev V.I.

More about the authors

Journal: Russian Annals of Ophthalmology. 2019;135(1): 59‑66

DOI: 10.17116/oftalma201913501159

Read: 2067 times

Download PDF (RU)
Contact the author
Table of contents

OXIDATIVE STRESS CORRECTION IN THE TREATMENT OF SEVERE KERATOCONJUNCTIVITIS SICCA IN PATIENTS WITH SJORGEN’S SYNDROME
OXIDATIVE STRESS CORRECTION IN THE TREATMENT OF SEVERE KERATOCONJUNCTIVITIS SICCA IN PATIENTS WITH SJORGEN’S SYNDROME

To cite this article:

Safonova TN, Gladkova OV, Boev VI. Oxidative stress correction in the treatment of severe keratoconjunctivitis sicca in patients with Sjorgen’s syndrome. Russian Annals of Ophthalmology. 2019;135(1):59‑66. (In Russ.)
https://doi.org/10.17116/oftalma201913501159

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Dete­rmination of indi­cations for antioxidant therapy at the stage of pregravidar preparation of patients with early fetal loss in anamnesis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):66-70
Oxidative stress in the pathogenesis of chro­nic headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):35-40
Alte­rations in the acti­vity of glutathione-dependent enzy­mes in erythrocytes of patients with acute pancreatitis of varying seve­rity. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):10-15
Oxidative stress and antioxidant protection in diso­rders of cere­bral circulation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):114-119
Arte­rial hype­rtension is an oxidative stress, as a pathogenetic target for the treatment of chro­nic cere­brovascular insu­fficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):84-90
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Sleep deprivation and the deve­lopment of oxidative stress in animal models. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):124-129
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Rela­tionship between oxidative stress patterns and proinflammatory cyto­kines in patients with poly­pous rhinosinusitis under the course of therapeutic physical factors. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(2):42-49
Abstract:

Purpose — to evaluate the antioxidative effect of artificial tears in the treatment of keratoconjunctivitis sicca (KCS). Material and methods. The study included 43 patients (60 eyes) with severe KCS: 38 women (50 eyes) and 5 men (10 eyes) aged from 27 to 76 years (in average 52 years). Patients were randomly divided into 2 groups; all patients used therapeutic silicone hydrogel soft contact lens (SCL) and instillations of 0.05% Cyclosporin A (CyA) 2 times a day. Patients of the first group (22 people, 30 eyes) used 0.15% hyaluronic acid. In the second group, patients (21 people, 30 eyes) used a tear substitute with similar surface-active component, but with antioxidant properties. The results of the treatment were evaluated using basic and additional research methods at 1, 3, 6 and 12 months. Results. Corneal epithelialization was achieved after 1 month of conservative treatment in all patients who wore SCLs and were treated with instillations of 0.05% CyA and artificial tears. Then the lenses were removed and the patients were switched to instillations of CyA and artificial tears. Comparative analysis of the results showed that higher functional indicators were achieved in the second group, where patients used Artelac Rebalance drops with antioxidant properties. Conclusion. Improvement of clinical and functional parameters in the treatment of severe forms of KCS was achieved by direct action on both links of pathogenesis with minimal amounts of the drugs and the frequency of their use. Subsequent supportive therapy contributed to stabilization of the results and further increase of the functional parameters.

Keywords:

keratoconjunctivitis sicca
Cyclosporin A
tear substitutes
oxidative stress

Authors:

Safonova T.N.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Gladkova O.V.

Research Institute of Eye Diseases, 11 A, B, Rossolimo St., Moscow, Russian Federation, 119021

Boev V.I.

Research Institute of Eye Diseases, 11 A, B, Rossolimo St., Moscow, Russian Federation, 119021

Close metadata

References:

  1. Safonova TN, Vasil’ev VI, Lihvanceva VG. Sindrom Shegrena. Rukovodstv odlya vrachej. M.: Izdatel’stvo moskovskogo universiteta; 2013. (In Russ.)
  2. Zoukhri D. Effect of inflammation on lacrimal glandfunction. Exp Eye Res. 2006;82(5):885-898. https://doi.org/10.1016/j.exer.2005.10.018
  3. Chighizola CB, Ong VH, Meroni PL. The Use of Cyclosporine A in Rheumatology: Comprehensive Review. Clinical Reviews in Allergy and Immunology. 2016;52:401-423. https://doi.org/10.1007/s12016-016-8582-3
  4. Devecı H, Kobak S. The efficacy of topical 0.05% cyclosporine A in patients with dry eye disease associated with Sjögren’s syndrome. Int Ophthalmol. 2014;3:32-39. https://doi.org/10.1007/s10792-014-9901-4
  5. Donnenfeld E, Pflugfelder SC. Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol. 2009;54(3):32-138. https://doi.org/10.1016/j.survophthal.2009.02.002
  6. Turrents JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep. 1997;17:3-8. https://doi.org/10.1007/978-1-4614-3573-0_6
  7. Perricone C, De Carolis C, Perricone R. Glutathione: a key player in autoimmunity. Autoimmunity Rev. 2000;8:697-701. https://doi.org/10.1016/j.autrev.2009.02.020
  8. Hongiun Du, Xu Xiao, Travis Stiles, et al. Novel Mechanistic Interplay between Products of Oxidative Stress and Components of the Complement System in AMD Pathogenesis. Open J Ophthalmol. 2016;6(1):43-50. https://doi.org/10.4236/ojoph.2016.61006
  9. Kruk J, Kubasik-Kladna K, Aboul-Enein HY. The role oxidative stress in the pathogenesis of eye diseases: current status and a dual role of physical activity. Mini Rev Med Chem. 2015;16(3):241-257. https://doi.org/10.2174/1389557516666151120114605
  10. Hao Liu, Minie Sheng, Yu Liu, et al. Expression of SIRT1 and oxidative stress in diabetic dry eye. Int J Clin Exp Pathol. 2015;8(6):7644-7653. https://doi.org/10.3724/sp.j.1008.2012.00621
  11. Yuichi Uchino, Tetsuya Kawakita, Masaki Miyazawa, et al. Oxidative Stress Induced Inflammation Initiates Functional Decline of Tear Production. PLoS One. 2012;7(10):45-48. https://doi.org/10.1371/journal.pone.0045805
  12. Pagano G, Gastello G, Pallardo F.V. Sjögren´s syndrome-associated oxidative stress and mitochondrial dysfunction: Prospects for chemoprevetion trials. Free Radical Research. 2013;47(3):71-73. https://doi.org/10.3109/10715762.2012.748904
  13. Wakamatsu TH, Dogru M, Matsumoto Y, et al. Evaluation of lipid oxidative stress status in Sjögren syndrome patients. Invest Ophthalmol Vis Sci. 2013;54(1):201-210. https://doi.org/10.1167/iovs.12-10325
  14. Macri A, Scanarotti C, Bassi AM, et al. Evaluation of oxidative stres levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15% and vitamin B12 eye drops. Graefes Arch Clin Exp Ophthalmol. 2015;253:425-430. https://doi.org/10.1007/s00417-014-2853-6
  15. Deng R, Hua X, Li J, et al. Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells. PLoS One. 2015;10:1-16. https://doi.org/10.1371/journal.pone.0126561
  16. Yanwei LI, Haifeng Liu, Wei Zeng, Jing Wei. Edaravone protects against hyperosmolarity-induced oxidative stress and apoptosis in primary human corneal epithelial cells. PLoS One. 2017;12(3):17-20. https://doi.org/10.1371/journal.pone.0174437
  17. Clouzeau C, Godefroy D, Riancho L, et al. Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro. Mol Vis. 2012;18:851-863. https://doi.org/10.1016/j.toxlet.2011.05.546
  18. Choi W, Lian C, Ying L, et al. Expression of Lipid Peroxidation Markers in the Tear Film and Ocular Surface of Patients with Non-Sjogren Syndrome: Potential Biomarkers for Dry Eye Disease. Curr Eye Res. 2016;41(9):1143-1149. https://doi.org/10.3109/02713683.2015.1098707
  19. Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012;31(3):271-285. https://doi.org/10.1016/j.preteyeres.2012.02.003
  20. Romano MR, Biagioni F, Carrizzo A, et al. Effects of vitamin B12 on the corneal nerve regeneration in rats. Exp Eye Res. 2014;120:109-117. https://doi.org/10.1016/j.exer.2014.01.017
  21. AL-Maskari M WMI, Ali A, et al. Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes. Nutrition. 2012;28:7-8. https://doi.org/10.1016/j.nut.2012.01.005
  22. Nezzar H, Mbekeani JN, Noblanc A, et al. Investigation of antioxidant systems in human meibomian gland and conjunctival tissues. Exp Eye Res. 2017;165:99-104. https://doi.org/10.1016/j.exer.2017.09.005
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.